News in brief: NASH/NAFLD Clinical Care Pathway App; Former AMA leader describes ‘gluten brain’; RACP calls for urgent action on COVID-19 vaccination for people with disability

NASH/NAFLD Clinical Care Pathway App A Clinical Care Pathway providing guidance on the screening, diagnosis, and treatment of non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) has been developed by the American Gastroenterological Association. According to the AGA, the guidance was developed by a multidisciplinary panel of experts and is intended to be applicable in any ...

Already a member?

Login to keep reading.

© 2021 the limbic